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Intracellular replication of Salmonella enterica serovar Typhimurium within membrane-bound
compartments, called Salmonella-containing vacuoles, depends on the activities of several
effector proteins translocated by the Salmonella pathogenicity island 2 (SPI-2)-encoded type III
secretion system. The SPI-2 effector protein SseJ shows similarity at the amino acid level to
several GDSL lipases with glycerophospholipid:cholesterol acyltransferase (GCAT) activity. In
this study, we show that catalytic serine-dependent phospholipase A (PLA) and GCAT activity of
recombinant SseJ is potentiated by factor(s) present in HeLa cells, RAW macrophages and
Saccharomyces cerevisiae. SseJ activity was enhanced with increasing amounts of, or
preincubation with, eukaryotic cell extracts. Analysis of the activating factor(s) shows that it is
soluble and heat- and protease-sensitive. We conclude that PLA and GCAT activities of SseJ are
potentiated by proteinaceous eukaryotic factor(s).
INTRODUCTION
Salmonella enterica serovar Typhimurium (S. Typhimurium)
invades a variety of host cell types and replicates intracellularly
within a membrane-bound compartment, the Salmonella-
containing vacuole (SCV). Numerous Salmonella virulence
genes are required for growth of this pathogen in mice; several
of these are associated with the Salmonella pathogenicity island
2 (SPI-2) type III secretion system (T3SS). This is expressed
upon bacterial entry into host cells and translocates a variety of
effector proteins across the SCV into the host cell (Cirillo et al.,
1998; Waterman & Holden, 2003). A functional SPI-2 T3SS is
essential for intracellular survival and systemic growth of
Salmonella in mice (Hensel et al., 1995; Ochman et al., 1996).
Approximately 20 SPI-2 effectors have been identified to date,
but their molecular functions remain largely unknown (Haraga
et al., 2008; Waterman & Holden, 2003).
The effector protein SseJ is encoded outside SPI-2, but
translocated via the SPI-2 T3SS (Miao & Miller, 2000).
Interestingly, deletion of sseJ does not have a detectable
effect on replication of S. Typhimurium in epithelial cells
or macrophage-like cell lines, but results in a mild
replication defect in elicited peritoneal macrophages
(Ruiz-Albert et al., 2002) and reduced virulence after
intraperitoneal inoculation of BALB/c mice (Freeman et al.,
2003; Ruiz-Albert et al., 2002). SseJ has been linked
functionally to SifA by virtue of the phenotype of a sifA sseJ
double mutant (Ruiz-Albert et al., 2002). SifA is a SPI-2
T3SS effector required for the formation of tubules (called
Sifs) that extend from SCVs in epithelial cells (Stein et al.,
1996). sifA mutants fail to make Sifs and gradually lose
their vacuolar membrane (Beuzon et al., 2000). However,
the process of vacuolar membrane loss is significantly
delayed in a sifA sseJ double mutant (Ohlson et al., 2005;
Ruiz-Albert et al., 2002), suggesting that SseJ may help to
destabilize the SCV membrane around the sifA mutant.
Furthermore, deletion of sseJ has been shown to result in
increased levels of Sifs (Birmingham et al., 2005).
Therefore, SseJ appears to oppose the activity of SifA.
The N-terminal domain of SseJ contains a translocation
signal also found in some other SPI-2 effector proteins:
SspH1, SspH2, SlrP, SifA, SifB and SseI (Miao & Miller,
2000). The C-terminal region (amino acids 140–408) is
29% identical to several members of the GDSL lipase
family, with highest similarity at the amino acid sequence
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(GCAT) found in Aeromonas hydrophila (Brumlik &
Buckley, 1996; Miao & Miller, 2000). Members of the
GDSL family of lipases are characterized by the presence of
a conserved GDSL motif and a catalytic triad (S-D-H)
(Akoh et al., 2004; Upton & Buckley, 1995). Mutation of
residues of the catalytic triad causes loss of lipolytic and
acyltransferase activity (Brumlik & Buckley, 1996).
Alignment of SseJ with GCAT (Flieger et al., 2002) reveals
the presence of a GDSL motif as well as the conserved
catalytic triad (S151, D274, H384). In agreement with these
predicted catalytic residues, recent studies have shown that
the virulence attenuation of DsseJ in mice cannot be
rescued by expression of SseJS151A, SseJD274N or SseJH384N,
indicating that these residues are important for function of
SseJ in vivo (Ohlson et al., 2005). In vitro, S151, D247 and
H384 have been shown to be necessary for deacylase
activity of recombinant SseJ (Ohlson et al., 2005),
supporting the notion that these represent a catalytic triad
similar to those of other GDSL lipases (Ohlson et al., 2005).
Recently, SseJ has been shown to esterify cholesterol in
vitro, in HeLa cells and macrophages (Nawabi et al., 2008).
In this study, we analysed the biochemical activity of SseJ.
We show that SseJ exhibits phospholipase A (PLA) and
GCAT activity and that both enzymic activities require the
presence of a eukaryotic activator.
METHODS
Bacterial strains and growth conditions. Escherichia coli was
grown in Luria–Bertani (LB) medium supplemented with carbenicillin
(50 mgm l
21) when appropriate. Saccharomyces cerevisiae AH 109 was
grown in YPD medium supplemented with 20 mg l
21 adenine hemi-
sulfate (YPDA). Strains used in this study are summarized in Table 1.
Reagents. Lipofectamine 2000 transfection reagent was purchased
from Invitrogen. 1,2-Dipalmitoylphosphatidylcholine (DPPC) and 1-
monopalmitoyllysophosphatidylcholine (1-MPLPC) were purchased
from Avanti Polar Lipids. Cholesterol and cholesteryl oleate, para-
nitrophenyl butyrate (PNPB), esterase from porcine liver, phospho-
lipase A2 (PLA2) from porcine liver and protease inhibitors
(aprotinin, leupeptin, pepstatin A) were obtained from Sigma.
[
3H]cholesterol (specific activity 40 Ci mmol
21; 1.5 TBq mmol
21)
was purchased from American Radiolabelled Chemicals.
Cell culture. HeLa (93021013) and RAW 264.7 (91962702) cells were
obtained from the European Collection of Cell Cultures, Salisbury,
UK, and grown in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum (FCS) and 2 mM glutamine
at 37 uCi n5%C O 2.
Plasmids. Expression plasmids pmyc::sseJ and pmyc::sseJS151V have
been described previously (Ruiz-Albert et al., 2002). pmyc::sseJ
expresses a full-length version of SseJ bearing an N-terminal fusion to
the c-myc epitope tag in pRK5-myc (Lamarche et al., 1996).
pmyc::sseJS151V expresses a catalytically inactive SseJS151V bearing
an N-terminal fusion to the c-myc epitope tag. pGEX4T2::sseJ was
used for expression of GST–SseJ. This plasmid (kindly provided by Dr
Ste ´phane Me ´resse, Centre d’Immunologie de Marseille-Luminy,
France) contains sseJ under the control of an IPTG-inducible
promoter. The plasmid pGEX4T2::sseJmt was constructed by site-
directed mutagenesis of pGEX4T2::sseJ, using the primers sseJ-1 (59-
TTTTGGCGACGTCTTGTCTGACTCC-39) and sseJ-2 (59-CCATAA-
AAAACCGCTGCAGAACAGACTG-39) and Pfu Ultra-high-fidelity
polymerase (Stratagene). pGEX4T2::sseJmt expresses a catalytically
inactive version of full-length SseJ, in which S in position 151 is
replaced by V, fused to the C terminus of glutathione-S-transferase
(GST). All constructs were verified by DNA sequencing prior to use.
Plasmids used in this study are summarized in Table 1.
Transfection. HeLa cells (5610
5) were seeded in six-well plates 24 h
prior to transfection with lipofectamine 2000 transfection reagent
according to the manufacturer’s manual (Invitrogen).
GST protein purification. Expression of GST fusion proteins was
induced with 0.5 mM IPTG (Sigma) in E. coli BL21 (DE3)
(Amersham Biosciences) at 25 uC for 4 h prior to collection of cell
pellets by centrifugation. Cells were resuspended in 40 mM Tris,
pH 7.4, containing Complete protease inhibitor cocktail (Roche) and
subsequently lysed by passage through a French Press. The soluble
fraction was isolated by ultracentrifugation at 130000 g and
subsequently incubated with glutathione–Sepharose beads
(Amersham Biosciences) for 2 h at 4 uC. Beads were washed with
PBS and 40 mM Tris, 100 mM NaCl, pH 8.0, before fusion proteins
were eluted using 10 mM glutathione (Sigma), dialysed in 40 mM
Tris, pH 7.4, and concentrated before use using Amicon-10 filter
devices (Millipore).
Cell extracts. HeLa and RAW 264.7 cells were grown in 175 cm
2
dishes to 80% confluence, scraped into ice-cold PBS, pelleted at 200 g
for 5 min and resuspended in homogenization buffer [8.5% sucrose
(w/v), 3 mM imidazole]. HeLa cells were broken by passage through a
22G needle; RAW 264.7 cells were broken by passage through a 27G
needle. Postnuclear supernatant (PNS) was obtained after centrifu-
gation at 1500 g for 5 min at 4 uC. Membranes and cytosol fractions
Table 1. Strains and plasmids used in this study
Strain Description Reference/source
Sacc. cerevisiae AH 109 Sacc. cerevisiae BD Biosciences, Clontech
E. coli BL21 (DE3) E. coli BL21 (DE3) Amersham Biosciences
S. Typhimurium 12023 Wild-type S. Typhimurium NTCC (Colindale, UK)
pGEX4T-2 Vector containing gene encoding GST Amersham Biosciences
pGEX4T2::sseJ Vector expressing GST–SseJ This study
pGEX4T2::sseJmt Vector expressing GST–SseJS151V This study
pmyc::sseJ pRK5myc::sseJ Ruiz-Albert et al. (2002)
pmyc::sseJS151V pRK5myc::sseJS151V Ruiz-Albert et al. (2002)
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1 h. Where indicated, HeLa cell cytosol was further treated by
incubation with 250 mg trypsin ml
21 for 15 min at 30 uC, followed by
addition of the trypsin inhibitor aprotinin. For preparation of Sacc.
cerevisiae cell extract, Sacc. cerevisiae AH109 was grown overnight in
YPDA medium at 30 uC, and cells were resuspended in 50 mM
Na3PO4 buffer, pH 7.4, supplemented with protease inhibitors [10 mg
aprotinin ml
21,5 mg leupeptin ml
21,1 mM pepstatin A and
Complete protease inhibitor cocktail (Roche)]. Cells were broken by
four passages through a French Press and the soluble cell extract was
obtained after pelleting of cell debris by centrifugation at 14000 g for
30 min. E. coli BL21 soluble extract was prepared from an overnight
culture resuspended in 40 mM Tris, pH 7.4, containing Complete
protease inhibitor cocktail (Roche) by passage through a French Press
and subsequent ultracentrifugation at 130 000 g.
Deacylase assay. The PNPB deacylase assay was carried out as
described elsewhere (Bonelli & Jonas, 1989; Ohlson et al., 2005).
Briefly, 5 mg GST fusion protein was added to the assay reaction mix
[1 ml containing 50 mM PNPB, 20 mM Tris, pH 7.4, and 3%
acetonitrile (v/v)] in a cuvette, and A400 was monitored over 30 min
at 37 uC (UV-VIS spectrophotometer, Shimadzu UK). As a positive
control, porcine liver esterase (Sigma) was used.
Phospholipase assay. DPPC liposomes and 1-MPLPC micelles
were prepared in 1 ml 40 mM Tris, pH 7.4, by sonication with a
probe at a concentration of 13.4 mM. GST fusion proteins were pre-
incubated with cell lysate for 1 h at 37 uC (30 uC for yeast cell
extract), where indicated. In general, 5 mg GST fusion protein was
incubated at 37 uC at pH 7.4 for 2 h with 3.35 mM DPPC liposomes
(3.35 mM 1-MPLPC micelles for lysophospholipase assay), with or
without cell extract (100 ml if not otherwise stated; 7 mg protein
ml
21) in a final volume of 200 ml. Porcine liver PLA2 was used as a
positive control in 40 mM Tris, pH 7.4, supplemented with 10 mM
CaCl2. Free fatty acids (FFA) were quantified using a NEFA-C kit
(Wako) according to the manufacturer’s manual. To test whether
superoxide dismutase (SOD-1) activates SseJ, 5 mg GST fusion
protein was pre-incubated with 20 mg bovine SOD-1 (Sigma) in
150 ml 40 mM Tris, pH 7.4, at 37 uC for 1 h before addition of DPPC
at a final concentration of 3.35 mM and incubation for 2 h at 37 uC.
Acyltransferase assay. Liposomes of equimolar amounts of DPPC
and partially
3H-labelled cholesterol (5 mM) were prepared in
20 mM Tris, pH 7.4, 160 mM KCl and 1.4% (w/v) BSA by bath
sonication for 30 min. Liposomes (50 ml) were incubated with 5 mg
GST fusion protein and 100 ml eukaryotic cell lysate (7 mg ml
21)a t
37 uC for 2 h in a final volume of 250 ml. The reaction was stopped by
addition of 3 ml CHCl3:MeOH (1:2, v/v). Lipids were extracted by
the method of Bligh & Dyer (1959), and subsequently separated
by TLC on glass-backed Silica 60 plates using petroleum ether:
diethylether (8:2, v/v). The cholesterol ester (CE) fractions were
scraped into Betamax ES liquid scintillation fluid (MP Biomedicals)
and d.p.m. were measured.
Statistical analysis. For analysis of the significance of differences
between samples, Student’s t test was used. Differences denoted as
significant in the text fall below a P value of 0.05.
RESULTS
Lack of enzymic activity of recombinant SseJ
in vitro
To analyse the enzymic activity of SseJ in vitro, SseJ and
SseJS151V were purified as GST fusion proteins (Fig. 1a)
Fig. 1. SseJ does not display esterase or phospholipase activity in
vitro. (a) Expression and purification of SseJ and SseJS151V as
GST fusion proteins. Lanes: 1, purified GST–SseJ (2 mg); 2,
purified GST–SseJS151V (2 mg); 3, purified GST (2 mg). (b)
GST–SseJ, GST–SseJS151V or GST was incubated with PNPB
at 37 6C, pH 7.4, while A405 was monitored over 30 min. Porcine
liver esterase was used as a positive control. GST and GST–
SseJS151V were used as negative controls. These data represent
the mean from two independent experiments performed in
triplicate. (c) GST–SseJ, GST–SseJS151V or GST was incubated
with DPPC liposomes at pH 7.4. Released FFA were quantified
after 2 h incubation at 37 6C. PLA2 from bovine pancreas
functioned as a positive control. GST and GST–SseJS151V were
used as negative controls. The value of FFA following incubation
with GST alone was subtracted from values obtained after
incubation of DPPC with GST–SseJ or GST–SseJS151V. These
data represent the mean±SD derived from three independent
experiments performed in triplicate.
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and PLA activity. As positive controls, porcine liver esterase
was used to hydrolyse PNPB (Fig. 1b) and commercially
available PLA2 was used to hydrolyse DPPC in liposomes
(Fig. 1c). No enzymic activity was detected at pH 7.4 when
GST–SseJ was incubated with PNPB (Fig. 1b) or DPPC
liposomes (Fig. 1c). Liposomes consisting of equimolar
amounts of cholesterol and DPPC were also used to test
whether SseJ displays acyltransferase activity in vitro, but
no enzymic activity was detected (data not shown). To test
whether the absence of detectable activity was due to the
25 kDa GST tag at the N terminus of SseJ, the GST tag was
cleaved from the purified protein, but no activity was
detected (data not shown). SseJ and SseJS151V were also
purified as polyhistidine fusion proteins, but neither had
detectable enzymic activity under the assay conditions used
(data not shown).
SseJ displays PLA activity when expressed in
HeLa cells
Expression of SseJ following transfection of HeLa cells leads
to the formation of globular membranous compartments
(GMCs), which are dependent on the catalytic activity of
SseJ (Ruiz-Albert et al., 2002). As enzymic activity of
recombinant SseJ purified from E. coli was undetectable, we
investigated its biochemical activity after expression in
HeLa cells. HeLa cells were transfected with vectors
expressing myc-SseJ or catalytically inactive myc-
SseJS151V. Mock-transfected HeLa cells were used as a
negative control. Following transfection, HeLa cell lysates
were incubated with DPPC liposomes at pH 7.4, 37 uC for
2 h. Released FFA were then quantified. HeLa cell lysate
containing myc-SseJ led to the release of more than twice
as much FFA as lysate from mock-transfected cells or lysate
containing myc-SseJS151V (89.5±11.7 nmol FFA versus
34.0±10.5 nmol FFA and 34.4±6.8 nmol FFA, respect-
ively). This indicates that SseJ possesses PLA activity, which
is dependent on the catalytic S in position 151 in the
context of HeLa cell lysate.
Recombinant SseJ displays PLA activity in the
presence of HeLa cell extract
Since we were able to show phospholipase activity of SseJ
following its expression in HeLa cells, but not following its
purification after expression in E. coli, we hypothesized that
it might require a eukaryotic factor for activity. To test this,
the activity of GST–SseJ purified from E. coli was
monitored in the presence of HeLa cell PNS and DPPC
liposomes. Incubation of GST–SseJ with DPPC liposomes
together with HeLa cell PNS led to the release of
155.9±15.8 nmol FFA compared to 69.7±14.4 nmol and
69.1±17.3 nmol FFA detected after incubation with GST–
SseJS151V and purified GST, respectively (Fig. 2a). In the
absence of PNS, FFA was detected at similar low levels
following incubation of DPPC liposomes with GST–SseJ,
GST–SseJS151V or GST (Fig. 2a). These results show that a
factor present in HeLa cell extract is required for PLA
activity of SseJ. Incubation of increasing amounts of GST–
SseJ with a fixed amount of DPPC liposomes and a fixed
Fig. 2. (a) Phospholipase activity of SseJ requires the presence of
a eukaryotic factor. GST–SseJ, GST–SseJS151V or GST was
incubated with DPPC liposomes in the presence or absence of
HeLa cell PNS for 2 h at 37 6C, pH 7.4, before released FFA were
quantified. Data represent mean±SD derived from three inde-
pendent experiments performed in triplicate. (b) Phospholipase
activity is dependent on SseJ concentration, but limited by the
amount of activator. A fixed amount of HeLa cell extract (0.8 mg
protein) was incubated with 1–7.5 mg GST–SseJ ($), GST–
SseJS151V (m) or GST for 2 h at 37 6C, pH 7.4, before FFA were
quantified. Values of FFA following incubation with GST were
subtracted from values obtained by incubation of DPPC with
equivalent amounts of GST–SseJ or GST–SseJS151V. These
data represent the mean derived from two independent experi-
ments performed in triplicate. (c) Phospholipase activity as a
function of PNS protein amounts. GST–SseJ (5 mg) (&) or GST
was incubated with a range of concentrations of HeLa cell PNS
from 0 to 1.1 mg protein at pH 7.4. Released FFA were quantified
after 2 h incubation at 37 6C. Values obtained with GST alone
were subtracted from values obtained with GST–SseJ. These data
represent the mean derived from two independent experiments
performed in triplicate.
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http://mic.sgmjournals.org 2683amount of HeLa cell extract led to an increase in the
amount of released FFA up to approximately 5 mg GST–
SseJ, after which production of FFA plateaued (Fig. 2b). To
determine whether the substrate concentration or activ-
ating factors were limiting under these conditions, 5 mg
GST–SseJ and DPPC liposomes were incubated with an
increasing amount of eukaryotic cell extract, which led to a
linear increase in released FFA (Fig. 2c). This shows that
HeLa cell-derived factor(s) limit the reaction under the
assay conditions used.
SseJ does not display lysophospholipase activity
To analyse whether SseJ hydrolyses lysophospholipids,
GST–SseJ, GST–SseJS151V or GST was incubated with 1-
MPLPC micelles at 37 uC, pH 7.4 for 2 h in the presence of
HeLa cell PNS. In contrast to incubation of GST–SseJ with
DPPC liposomes, the amount of FFA after incubation of
GST–SseJ with 1-MPLPC micelles did not significantly
differ from the amount of FFA detected in the presence of
GST–SseJS151V or GST (Fig. 3). Therefore, SseJ does not
exhibit lysophospholipase activity at pH 7.4 in the presence
of HeLa cell PNS using 1-MPLPC micelles as a substrate.
HeLa cell extract-activated SseJ displays GCAT
activity
To test whether SseJ can carry out acyl transfer in the
presence of eukaryotic activator, GST–SseJ, GST–
SseJS151V or GST was incubated in the presence of HeLa
cell PNS with liposomes comprising an equimolar mix of
DPPC and partially
3H-labelled cholesterol. The formation
of
3H-labelled CE was measured after lipid extraction and
separation via TLC. In the presence of GST–SseJ and HeLa
cell PNS, 58214.8±1162.6 d.p.m. were detected in the CE
fraction, while GST–SseJS151V and GST produced
5543.7±1418.5 d.p.m. and 4011.6±1710.3 d.p.m.,
respectively, demonstrating that SseJ possesses GCAT
activity in the presence of HeLa cell extract (Fig. 4).
Analysis of the SseJ-activating factor(s)
HeLa cell extract was required for PLA and GCAT activity
of SseJ in vitro. In addition to HeLa cell extract, mouse
macrophage RAW 264.7 cell extract contained factor(s)
that activated SseJ (Fig. 5a). Soluble extracts of E. coli, S.
Typhimurium or Sacc. cerevisiae did not activate SseJ (Fig.
5a and data not shown). Interestingly, the activity of GST–
SseJ was detectable when GST–SseJ was pre-incubated with
Sacc. cerevisiae extract at 30 uC for 1 h before addition of
DPPC liposomes and incubation for 2 h at 37 uC (FFA
released without pre-incubation, 88.38±4.84 nmol; FFA
released after pre-incubation, 132.48±14.9 nmol FFA)
indicating that Sacc. cerevisiae extract also contained SseJ-
activating factor(s) (Fig. 5b). Similarly, incubation of GST–
SseJ with HeLa cell extract for 1 h at 37 uC prior to
addition of DPPC liposomes also led to an increase in
released FFA compared to FFA released by GST–SseJ that
was incubated with activator and substrate simultaneously
(221.50±24.69 nmol FFA versus 149.48±22.12 nmol)
(Fig. 5b). However, pre-incubation of GST–SseJ with E.
coli soluble extract did not result in detectable PLA activity
of GST–SseJ. We conclude that SseJ was activated by
factor(s) present in Sacc. cerevisiae extract only after
pre-incubation, suggesting that the concentration of
activator might be lower in yeast extract than in HeLa or
RAW cell extract.
Several phospholipases are known to require divalent
cations, such as Ca
2+ (Clark et al., 1991; Dessen et al.,
1999; Reynolds et al., 1993). The addition of 10 mM CaCl2,
Fig. 3. SseJ does not show lysophospholipase activity in vitro.
GST–SseJ, GST–SseJS151V or GST was incubated with DPPC
or 1-MPLPC liposomes at pH 7.4 in the presence of HeLa cell
lysate for 2 h at 37 6C before FFA were quantified. Lysis of DPPC
by GST–SseJ served as a positive control. GST and GST–
SseJS151V were used as negative controls for both DPPC and 1-
MPLPC lysis. These results represent the mean±SD for each
sample (in triplicate), and are representative of two independent
experiments.
Fig. 4. SseJ displays GCAT activity in the presence of HeLa cell
PNS. GST–SseJ, GST–SseJS151V or GST was incubated with
DPPC/cholesterol (1:1, mol/mol) liposomes containing
[
3H]cholesterol in the presence of HeLa cell PNS at pH 7.4.
After 2 h incubation, lipids were extracted and separated by TLC.
Levels of [
3H]CEs were measured by detection of d.p.m. in the CE
fraction. These results represent the mean±SD for each sample (in
triplicate) and are representative of three independent experi-
ments.
N. S. Lossi and others
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in vitro (data not shown). Fractionation of HeLa cell PNS
into cytosolic and membrane fractions prior to addition to
the assay demonstrated that the activator was mainly
retained in the cytosolic fraction (Fig. 6a). Incubating HeLa
cell cytosol at 56 uC decreased its ability to activate SseJ and
treatment of cytosol at 100 uC led to a complete loss of
activating ability (Fig. 6b). When cytosol was pre-treated
with trypsin before incubation with SseJ, the activating
ability of the extract was reduced (Fig. 6c). After subjecting
cytosol to size-exclusion filtration with 100 kDa cut-off,
the activating factor was retained in the .100 kDa fraction
Fig. 5. (a) GST–SseJ, GST–SseJS151V or GST was incubated
with DPPC liposomes at 37 6C, pH 7.4, in the presence of cell
lysates extracted from HeLa cells, RAW macrophages, Sacc.
cerevisiae (Yeast) or E. coli. Released FFA were quantified after
2 h incubation. (b) GST–SseJ, GST–SseJS151V or GST was
incubated with HeLa cell, E. coli or Sacc. cerevisiae extract for 1 h
at 37 or 30 6C( Sacc. cerevisiae), respectively, before addition of
DPPC liposomes. FFA were quantified after further incubation at
37 6C for 2 h (HeLa+/Yeast+/E. coli+). Released FFA were
compared to FFA released in identical assays without pre-
incubation of GST fusion proteins (HeLa”/Yeast”/E. coli”). (c)
GST–SseJ, GST–SseJS151V or GST (5 mg) was pre-incubated
with 20 mg SOD-1 for 1 h at 37 6C before addition of DPPC. In a
final volume of 200 ml, FFA were quantified after further incubation
for 2 h at 37 6C. Results shown in (a–c) represent the mean±SD
for each sample (in triplicate) and are representative of two
independent experiments.
Fig. 6. GST–SseJ, GST–SseJS151V or GST was incubated with
DPPC liposomes in the presence of HeLa cell extract. Conditions
of cell extract preparation are described below. Data represent the
amount of FFA quantified after incubation of GST fusion proteins
with DPPC liposomes and cell extract for 2 h at 37 6C. (a) PNS of
HeLa cells was fractionated into cytosolic and membrane fractions
by ultracentrifugation. Equivalent proportions of cytosol and
membrane fraction were added to the assay. Data shown
represent mean±SD derived from three independent experiments.
(b) HeLa cell cytosol was subjected to 37 6C for 30 min, 56 6C
for 30 min or 100 6C for 5 min before addition to the phospho-
lipase assay. Data represent mean±SD derived from two
independent experiments performed in triplicate. (c) HeLa cell
cytosol was pre-treated with trypsin for 15 min. The pre-treated
cytosol was added to the phospholipase assay after addition of the
protease inhibitor aprotinin. In the control, protease inhibitor was
added to the cytosolic fraction before addition of trypsin. The
results represent the mean±SD for each sample (in triplicate) and
are representative of three independent experiments.
Eukaryotic activator-dependent activity of SseJ
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likely to be proteinaceous and to have a molecular mass
over 100 kDa or to be present in a complex with a mass of
.100 kDa.
To analyse whether cleavage or other covalent modification
of SseJ is responsible for its activation, macrophages were
infected with strains of S. Typhimurium expressing double
HA-tagged SseJ (SseJ–2HA) for 14 h. The electrophoretic
mobility of translocated SseJ was compared with SseJ
produced by S. Typhimurium grown in vitro.N o
differences in electrophoretic mobility were detected (data
not shown).
Superoxide dismutase (SOD-1) is known to be required for
the activity of ExoU, a T3SS effector with phospholipase
activity expressed by Pseudomonas aeruginosa (Sato et al.,
2006). GST–SseJ, GST–SseJS151V or GST was therefore
incubated with bovine SOD-1 in excess for 1 h at 37 uC
prior to addition of DPPC liposomes and further
incubation for 2 h at 37 uC, pH 7.4; however, no activity
of GST–SseJ was detected (Fig. 5c). Therefore, SseJ is likely
to be activated by a novel eukaryotic proteinaceous factor.
DISCUSSION
In this work we have analysed the biochemical activity of
SseJ, a Salmonella SPI-2 T3SS effector protein. We found
that both the PLA activity and the GCAT activity of SseJ
need to be activated by a factor or factors present in
eukaryotic cells. We have not yet established the identity of
the activator but it is likely to be proteinaceous. There is a
formal possibility that a dormant eukaryotic enzyme could
be activated (directly or indirectly) by SseJ. This can only
be ruled out (or confirmed) conclusively by identification
of the activator itself. However, a dormant eukaryotic
enzyme seems highly unlikely, given the amino acid
sequence similarity between SseJ and other GDSL lipases
and GCAT of A. hydrophila. Purified SseJ has been reported
to possess deacylase activity on PNPB (Ohlson et al., 2005)
and GCAT activity on phosphatidylcholine/cholesterol
liposomes (Nawabi et al., 2008). However, we were unable
to detect deacylase or GCAT activity of SseJ in the absence
of activator using very similar assay conditions to those
described elsewhere (Nawabi et al., 2008; Ohlson et al.,
2005).
The N-terminal 140 aa of SseJ have similarity to several
other SPI-2 effectors and contain a signal for its
translocation (Miao & Miller, 2000). The region of SseJ
encompassing amino acids 140–408, however, is similar to
several members of the GDSL lipase family, including
GCAT of Aeromonas spp. (26.8% amino acid identity)
(Brumlik & Buckley, 1996) and PlaC of Legionella
pneumophila (19.5% amino acid identity), which also
possesses GCAT activity (Banerji et al., 2005; Brumlik &
Buckley, 1996). The GDSL lipase family is characterized by
five conserved blocks of amino acids. The first contains the
GDSL motif including the catalytic serine, and the third
and fifth contain aspartic acid and histidine residues,
respectively; together with the serine in block 1 these
constitute the catalytic triad (Akoh et al., 2004). The
corresponding residues in SseJ (Table 2) are essential for
the function of the protein in vivo and for deacylase activity
in vitro (Ohlson et al., 2005), and we show in this paper
that the predicted catalytic serine in block 1 is essential for
both PLA and GCAT activity when stimulated by
eukaryotic cell extract. It is not clear why Nawabi et al.
(2008) were able to detect GCAT activity in the absence of
the activator while we were not. It is possible that
differences in methods of enzyme expression and purifica-
tion, substrate choice (synthetic DPPC versus natural egg
phosphatidylcholine) or lipid extraction could have
revealed activity in the absence of eukaryotic activator.
Notwithstanding this discrepancy, we have clearly demon-
strated that the GCAT activity of SseJ is significantly
enhanced after exposure to (a) eukaryotic factor(s).
Both GCAT and PlaC need to be activated by proteases
(Banerji et al., 2005; Vipond et al., 1998). GCAT activity is
potentiated as a result of proteolytic processing by AspA,
the major secreted serine protease of Aeromonas salmoni-
cida (Hilton et al., 1990; Vipond et al., 1998). Pro-GCAT
(37 kDa) is cleaved at two sites, resulting in three GCAT
fragments, two of which are connected via a disulfide bond
(33 kDa), so that only a very small fragment of pro-GCAT
is lost (Vipond et al., 1998). Both pro- and processed
GCAT possess activity in vitro, but only processed GCAT
can penetrate lipid monolayers at surface pressures
equivalent to those of natural membranes (.30 mN
m
21) (Hilton et al., 1990; Hilton & Buckley, 1991).
Activation of PlaC is dependent on the zinc metallopro-
tease ProA, although it is not clear whether this effect is
direct or indirect (Banerji et al., 2005). Despite these two
precedents, it seems unlikely that SseJ is activated by
proteolytic cleavage, since several protease inhibitors were
added to cell extracts prior to incubation with SseJ and no
size difference between intrabacterial and translocated SseJ
was detected by Western blotting. Another difference from
GCAT and PlaC is that SseJ requires (a) eukaryotic
factor(s) for its activity. ExoU, a P. aeruginosa T3SS
effector protein with PLA2 activity (belonging to the
patatin-like lipase family), also requires a eukaryotic
activator, which has recently been identified as superoxide
dismutase (SOD-1) (Sato et al., 2006). However, the
mechanism by which SOD-1 activates ExoU has not yet
been elucidated. Purified bovine SOD-1 did not activate
SseJ in vitro, and it therefore seems likely that SseJ is
activated by a unique mechanism. Attempts to identify the
eukaryotic activator(s) are underway and this will provide
further insight into the mechanism of activation of SseJ.
It is interesting to consider how the GCAT activity of SseJ
might influence the biology of the SCV. SseJ is translocated
by the SPI-2 T3SS and localizes to the cytosolic face of the
vacuole and Sifs (Freeman et al., 2003), tubular extensions
of the SCV which form along microtubules, and which are
particularly noticeable in epithelial cells (Garcia-del
N. S. Lossi and others
2686 Microbiology 154Portillo et al., 1993). Therefore, SseJ is likely to act on
phospholipids, present in the SCV membrane and Sifs,
transferring acyl chains to cholesterol, which appears by
microscopy to be particularly abundant in the SCV
membrane (Catron et al., 2002). Although the resolution
of light microscopy does not allow one to conclude that
cholesterol is present in the SCV membrane itself,
immunolabelling of intra-vacuolar Salmonella after expo-
sure of the SCV to saponin (a cholesterol-dependent
membrane-permeabilizing reagent) indicates that choles-
terolispresentintheSCVmembrane.ThefunctionofSseJis
linked to that of SifA, an SPI-2 T3SS effector whose function
has been clarified in recent years. Following translocation
and localization to the SCV membrane and Sifs, SifA is
prenylatedandanchored in the SCV membrane of SCVsand
Sifs (Reinicke et al., 2005). SifA binds to SKIP, a host cell
protein that prevents the microtubule motor kinesin from
being recruited to the SCV. sifA mutants fail to induce the
formation of Sifs (Stein et al., 1996) and gradually lose their
vacuolar membranes (Beuzon et al., 2000) in a kinesin-
dependent manner (Guignot et al., 2004).
Two intracellular phenotypeshave been described that result
from mutation of sseJ. First, the loss of vacuolar membrane
around sifA mutants requires the activity of SseJ (Ruiz-
Albert et al., 2002), and second, deletion of sseJ induces the
formation of more Sifs per cell, suggesting that SseJ inhibits
Sif formation (Birmingham et al., 2005). Therefore, SseJ
appears to oppose the activity of SifA. If the GCAT activity
of SseJ in the SCV membrane esterifies cholesterol and
removes it from the SCV to lipid droplets (Nawabi et al.,
2008), its absence could increase membrane rigidity,
facilitating kinesin-mediated rupture of vacuolar mem-
branes around sifA mutant bacteria. Membrane association
of prenylated Rab proteins is dependent on the cholesterol
content of the membrane (Chen et al., 2008; Lebrand et al.,
2002). Hence, by regulating the amount of cholesterol in the
SCV membrane, SseJ could control the amount of SifA on
the SCV. In the sseJ mutant, more cholesterol could lead to
greater incorporation of SifA into the SCV membrane and
thereby to an increased level of Sif formation.
The dynamic properties of the SCV membrane are also
likely to be altered by SseJ-mediated deacylation of
phospholipids, since membrane curvature is affected by
the lipid composition of the phospholipid bilayer
(McMahon & Gallop, 2005). Furthermore, GCAT activity
could influence host cell signalling pathways by affecting
lipid raft composition through its effect on cholesterol and
by generating FFA and lysophospholipid.
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